Synergy Pharmaceuticals, Inc.

Synergy Pharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: NY, United States

: | Nasdaq: SGYP | Nasdaq: SGYPW | Nasdaq: SGYPU

Similar to: Recordati SpA, United-Guardian, Inc., Shire PLC

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its proprietary drug candidate Plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the Guanylate Cyclase C receptor on epithelial cells of the GI tract. The company was founded on November 15, 2005 and is headquartered in New York, NY.

News & Analysis

You may also be interested in: